5,12-NAPHTHACENEDIONE, 8-ACETYL-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-10-((2,3,6-TRIDEOXY-3-((N-(N,N-DIMETHYLGLYCYL)GLYCYL)AMINO)-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-, MONOHYDROCHLORIDE, (8S-CIS)-
UNII 3G365OSY3E
Substance Identification & Data
This profile provides standardized clinical and technical data for 5,12-naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-((n-(n,n-dimethylglycyl)glycyl)amino)-.alpha.-l-lyxo-hexopyranosyl)oxy)-, Monohydrochloride, (8s-cis)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3G365OSY3E.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 58161-65-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C33H39N3O12.ClH ZVPGKONLVQAMJZ-SGLHZKEVSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5,12-naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-((n-(n,n-dimethylglycyl)glycyl)amino)-.alpha.-l-lyxo-hexopyranosyl)oxy)-, Monohydrochloride, (8s-cis)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.